samedan logo
 
 
 
spacer
home > ebr > spring 2004 > what is a cancer drug worth?
PUBLICATIONS
European Biopharmaceutical Review

What is a Cancer Drug Worth?

Frequently, the specific merits of individual companies are overlooked as the values of those companies fluctuate along with the broader stock markets of which they are constituents. So too are the values of licensing deals governed by external factors that are quite unrelated to the true 'worth' of the drugs being licensed. This is as true of deals for development-stage oncology products as it is for any other type of licensing agreement, but the huge number of variables involved in this - one of the most inscrutable of therapy areas - makes searching for appropriate deal terms all the more difficult. The following analysis looks at some recent cancer deals and explores some of the determining variables that influenced the headline values of those deals.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Rupert Winckler is a Consultant with PharmaVentures, a UK-based pharmaceutical strategy consultancy he joined in 2001. He gained his degree in Molecular and Cellular Biochemistry from the University of Oxford and holds a Diploma in Financial Management from the ACCA. Prior to joining PharmaVentures, he worked for the London Stock Exchange, the Securities and Futures Authority, and the Forensic Accounting division of KPMG.
spacer
Rupert Winckler
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Injection vials for vaccines for protection against Covid-19

Düsseldorf, July 02, 2020 The vaccines under development to protect against Covid-19 are, like many other drugs, filled in so-called injection or vials made of type 1 borosilicate glass, also known as vials. The large worldwide demand for vials is met by the Gerresheimer Group's plants in Europe, America and Asia, where they are manufactured to high quality standards for customers in the pharmaceutical industry. The Company has already received initial orders for vials for drugs and vaccines against Covid-19.
More info >>

White Papers
 
Industry Events

BIO-Europe Digital

26-29 October 2020, Digitally delivered

Global connections are more important than ever. With the same powerful one-to-one partnering and valuable content, BIO-Europe Digital continues to help you drive your life science partnering forward.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement